TrialJAMA network open2023

Efficacy and Safety of Rivaroxaban for Postoperative Thromboprophylaxis in Patients After Bariatric Surgery: A Randomized Clinical Trial.

Dino Kröll et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.